why is there a shortage of semaglutide Novo Nordisk's officially concludes in the US, spelling major threat for weight loss drug compounders The impact of the Ozempic

Associated with better metabolic outcomes including weight, glucose, BMI, and blood pressure in clinical trials

Understanding these restrictions helps you make informed decisions about both your health treatment and community giving

FDA ramps up enforcement on GLP-1s, peptides, RUO labeling, and compounding practices

Transparent documentation and consistent quality control

This once-weekly treatment supports metabolic balance as part of a structured 3-month care plan

GoodRx, WeightWatchers, and LifeMD have launched the newly FDA-approved Wegovy pill (oral semaglutide) with a transparent $149 per month cash-pay price, signaling a major shift in obesity care